Aspirin, Plavix, and Other Antiplatelet Medications: What the Oral and Maxillofacial Surgeon Needs to Know

Oral Maxillofac Surg Clin North Am. 2016 Nov;28(4):497-506. doi: 10.1016/j.coms.2016.06.003. Epub 2016 Aug 29.

Abstract

Most patients with coronary artery disease and peripheral vascular disease are on long-term antiplatelet therapy and dual therapy. Achieving a balance between ischemic and bleeding risk remains an important factor in managing patients on antiplatelet therapy. For most outpatient surgical procedures, maintenance and continuation of this therapy are recommended. Consultation with the patient's cardiologist, physician, and/or vascular surgeon is always recommended before interrupting or withholding this treatment modality.

Keywords: Angioplasty; Antiplatelet therapy; Aspirin; Bleeding; Cardiac stenting; Clopidogrel; Coronary artery disease; Myocardial infarction.

Publication types

  • Review

MeSH terms

  • Aspirin / administration & dosage*
  • Aspirin / therapeutic use
  • Clopidogrel
  • Coronary Artery Disease / drug therapy
  • Humans
  • Medication Therapy Management
  • Oral Surgical Procedures*
  • Peripheral Vascular Diseases / drug therapy
  • Platelet Aggregation Inhibitors / administration & dosage*
  • Platelet Aggregation Inhibitors / therapeutic use
  • Ticlopidine / administration & dosage
  • Ticlopidine / analogs & derivatives*
  • Ticlopidine / therapeutic use

Substances

  • Platelet Aggregation Inhibitors
  • Clopidogrel
  • Ticlopidine
  • Aspirin